ATTD 2026: Review innovations in basal insulin dosing and the role of Smart Basal technology.
This resource is intended for educational purposes only for healthcare providers practicing in the United States. It does not constitute medical advice and is not a substitute for professional judgment or individualized patient care.
In this 20-minute presentation, Dr. Sean Oser reviews innovations in basal insulin initiation and titration, highlighting the use of Smart Basal technology to simplify basal insulin dosing and improve glycemic outcomes in adults with type 2 diabetes.
This presentation is part of the Transforming Diabetes Care:The Power of Dexcom CGM from Prediabetes to Insulin Therapy session recorded live at Advanced Technologies & Treatments for Diabetes (ATTD) 2026 in Barcelona, Spain on March 13, 2026.